Stack Financial Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-66,211
Closed -$4.74M 57
2016
Q4
$4.74M Sell
66,211
-4,595
-6% -$342K 0.53% 51
2016
Q3
$5.6M Buy
70,806
+65
+0.1% +$5.28K 0.65% 50
2016
Q2
$5.9M Buy
70,741
+1,365
+2% +$121K 0.75% 46
2016
Q1
$6.37M Sell
69,376
-10
-0% -$902 0.77% 45
2015
Q4
$7.02M Buy
69,386
+205
+0.3% +$21.3K 0.89% 43
2015
Q3
$6.79M Sell
69,181
-497
-0.7% -$55.2K 0.95% 45
2015
Q2
$8.16M Buy
+69,678
New +$7.61M 0.99% 46

Other funds holding GILD

Stack Financial Management's GILD Position: Q1 2017 in Review

Stack Financial Management sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 66,211 shares — an estimated $4.74M sold.

Stack Financial Management first reported a position in GILD in Q2 2015 and held it in 7 quarters. The position peaked at $8.16M in Q2 2015. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Stack Financial Management reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • Stack Financial Management sold 66,211 Gilead Sciences shares in Q1 2017, an estimated $4.74M.
  • Stack Financial Management first reported a position in Gilead Sciences in Q2 2015 and held it in 7 quarters.
  • Stack Financial Management's Gilead Sciences position peaked at $8.16M in Q2 2015.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Stack Financial Management's 13F filing for Q1 2017, filed 5 May 2017.